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Effectiveness of a Hydrogen Peroxide Mist
(Trophon) System in Inactivating Healthcare
Pathogens on Surface and Endocavitary Probes
Ultrasound probes are used in sonographic scanning and are
commonly used as either surface probes or endocavitary
probes. Surface probes are used on intact skin, such as the
abdomen; they are considered noncritical and require at least
low-level disinfection between patients. Endocavitary probes
(eg, transvaginal, transrectal, or transesophageal probes) are
considered semicritical because they have direct contact with
mucous membranes (eg, vagina, rectum, or pharynx) or non-
intact skin. While one could argue that the use of the probe
cover changes the category for the endocavitary probe, the
Centers for Disease Control and Prevention (CDC) guideline
for disinfection and sterilization recommends that a new
condom/probe cover should be used for each patient, and
because condoms/probe covers and low-level disinfection may
fail,1,2 high-level disinfection of the probe should be performed.3
The relevance of this recommendation is reinforced by the
finding that sterile ultrasound probe covers and condoms can
have a perforation rate from 0% to 81% before and after use.1
These studies underscore the need for high-level disinfection of
endocavitary probes between examinations.
Ultrasound probes may also be used during surgical proce-
dures and may have contact with sterile body sites. These probes
may be covered with a sterile sheath to reduce the level of con-
tamination on the probe and reduce the risk of infection. How-
ever, because the sheath does not provide complete protection of
the probe, the probes should be sterilized between each patient
use, as are other critical items. If this is not possible, then high-
level disinfection of the probe should be performed and the probe
should be covered with a sterile probe cover.1,3
Although the most common method of performing high-level
disinfection of contaminated endocavitary probes is by immer-
sion in a high-level disinfectant cleared by the Food and Drug
Administration (eg, glutaraldehyde), an alternative procedure
for disinfecting the endocavitary and surface probes uses a pro-
prietary hydrogen peroxide mist system, which utilizes 35%
hydrogen peroxide at 56°C with the probe reaching nomore than
40°C (ie, Trophon EPR, Nanosonics, Alexandria, Australia). The
effectiveness of this technology, which has been cleared by the
Food and Drug Administration for high-level disinfection,
is evaluated in this research brief.
This study was conducted at the University of North
Carolina (UNC) Hospitals, an 853-bed academic medical
center. Trophon EPR and 5 ultrasound probes were loaned to
UNC Hospitals for use in the study. In a biological safety
cabinet, at least 3 replicates of each probe type (ie, endocavitary
or surface probe) were inoculated in 3 specified locations with
one of the test organisms: vancomycin-resistant Enterococcus
[VRE] ATCC #51299, a clinical strain of carbapenem-resistant
Enterobacteriaceae [CRE] Klebsiella pneumoniae, Clostridium
difficile spores, or Mycobacterium terrae. These procedures
were fully repeated in a separate experiment to ensure accuracy
using the aforementioned defined set of test conditions.
The inoculae for VRE, CR-K. pneumoniae, M. terrae, and
C. difficile spores in the presence of 5% fetal calf serum
(FCS) produced inoculation levels of 5.59-log10, 5.91-log10,
5.88-log10, and 6.23-log10, respectively, and in the absence of
5% FCS they produced inoculation levels of 5.84-log10,
6.16-log10, 4.89-log10, and 6.29-log10, respectively. In total,
24 surface probes and 31 endocavitary probes were tested.
The presence and resistance of C. difficile spores (and not
vegetative bacteria) were verified by exposing the stock
preparation to dilute hydrochloric acid as specified in the
AOAC International sporicidal activity test.4
The 15 µL inoculum consisted of trypticase soy broth
(TSB; Becton, Dickinson and Company, Sparks, MD) with or
without 5% FCS (Remel, Lenexa, KS) as an organic challenge.
Each inoculum was spread over an area equal to the size of a
dime to prevent pooling of the inoculum. The probes were
then allowed to air dry for 30 minutes. After drying, each test
probe was processed in the Trophon EPR according to the
manufacturer’s instructions. A chemical indicator was used in
each cycle to ensure that the critical parameters of the cycle had
been met. After processing, the probe was evaluated for
surviving microbes by submerging the inoculated portion of
the probe in TSB (~400mL surface, ~1500mL endocavitary)
and shaking it at 80–100 rpm (Fisher Scientific Clinical Rotator,
Pittsburgh, PA) for a minimum of 1 hour. After shaking, the
TSB for each probe was filtered aseptically (0.2 µ pore size,
Thermo Scientific, Waltham, MA), and the filter was removed
and placed on media appropriate for each test organism. VRE,
CR Klebsiella pneumoniae, and C. difficile were all plated to
sheep blood agar, and Mycobacterium terrae was plated
to Middlebrook 7H11 Agar. All plates were then incubated at
35–37°C in a manner appropriate for each test organism:
aerobically for 48 hours for VRE and Klebsiella pneumoniae;
anaerobically for 48–96 hours for C. difficile; and aerobically
for 28 days for Mycobacterium terrae.
The results demonstrated complete inactivation (>6-log10
reduction) of VRE and a CR-K. pneumoniae strain both in the
presence and absence of 5% FCS (Table 1). The Trophon
EPR system showed good, but not complete, inactivation
of M. terrae (a 5.2-log10 reduction for M. terrae with FCS
and a 4.6-log10 reduction for M. terrae without FCS) and
C. difficile (a 5.1-log10 reduction for C. difficile spores with
FCS and a 6.2-log10 reduction for C. difficile spores without
FCS spores) (Table 1). To simulate a worst-case condition,
cleaning was not done prior to disinfection in these experiments,
but proper cleaning of probes is necessary to ensure the
success of high-level disinfection. Other pathogens that could
contaminate vaginal and rectal probes include human papilloma
virus.5 Published data have demonstrated the activity of
Trophon to inactivate HPV6 and other pathogens (eg, bacteria,
mycobacteria, and viruses), including a >6-log10 reduction of
M. terrae and C. difficile spores in carrier tests and a >6-log10
reduction in M. terrae on inoculated ultrasound probes.7 These
results differ slightly from those presented here, presumably due
to the differences in testing methodology. In our study, only the
probe devices were inoculated (ie, carriers of different materials
were not tested), and for recovery of bacteria on the probe, the
probes were immersed in media (ie, not swabbed,7 which would
likely result in a lower recovery rate).
The Trophon system processes the portion of the probe that
has contact not only with mucous membrane but also
with the handle of an endocavitary probes, which also
may be contaminated.8 It is an alternative to high-level
chemical disinfection for ultrasound probes.
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table 1. Proportion of Surface and Endocavitary Probes Positive After Trophon System Processing According to the Presence or Absence






Probes with CR Klebsiella
pneumoniae, No./Total
Probes with Mycobacterium
terrae, No./Total (mean log10
reduction and 95% CI)
Probes with Clostridium difficile
spores, No./Total (mean log10
reductions and 95% CI)
Present 0/7 0/6 4/9 (5.19 [4.61–5.76]) 3/6 (5.12 [4.42–5.83])
Absent 0/6 0/6 1/6 (4.62 [4.07–5.17]) 1/9 (6.23 [6.02–6.43])
*The inoculum control was handled like the test but not processed in the Trophon. Numbers represent a proportion of the number of probes
positive with the test organisms per number of probes tested. No statistical difference in the proportion of positive probes by test organism with
and without fetal calf serum (Fisher’s exact test; P> .05).
